X
Menu

+7 495 640-17-71
info@dna-technology.com

Search

News

Important news

We are pleased to invite you in our stand z4d41, to explore innovations of PCR technology. Reserve a time slot sending request to info@dna-technology.com
We are looking forward to meeting you!

20.01.2022

“DNA-Technology” has completed the quality assessment study of SARS-CoV-2 molecular detection coordinated by Quality Control for Molecular Diagnostics (QCMD), UK. The Panel  Composition included Alpha, Beta SARS-CoV-2 Variants, etc. The correct result was obtained in 100% of cases.

02.11.2021

First outbreak of the Candida auris, type of yeast or fungi, has been reported recently in the Texas and Washington, USA (source). This fungus is not dangerous for the people with strong immune system, but can be a big problem for those with the impaired immunity – people with chronic or opportunistic diseases.

26.07.2021

All news

The 38th conference of the European Society for Human Reproduction and Embryology (ESHRE) was held in Milan from July 3-6, 2022. Almost 12,000 participants from 128 countries took part in the conference program and visited the exhibition.
The products presented at our booth have aroused the keen interest of many specialists from different countries.

29.07.2022

ESHRE’s Annual meeting, which will take place in Milan from 3 to 6 July 2022, is a big international event where experts in reproductive medicine and science gather to participate in scientific sessions and above all network with their peers.

We are looking forward to meeting you!

24.06.2022

We present reports and posters of a study conducted under the guidance of Professor Ekaterina Voroshilina, Doctor of Medical Sciences on the 32nd European Congress of Clinical Microbiology & Infectious Diseases, Lisbon, Portugal on 23 - 26 April 2022.

Comparative analysis of semen microbiota by real-time PCR and culture-based technique
Prevalence of obligate fnftrobes of women with microscopicsigns of aerobic vaginitis according to real-time PCR

29.04.2022

“DNA-Technology” has completed the regular quality assessment study of SARS-CoV-2 molecular detection coordinated by Quality Control for Molecular Diagnostics (QCMD), UK.
The Panel Composition includes among others SARS-CoV-2 Delta Variant B.1.617.2. The obtained results were correct for all samples.
International Certificate and detailed QCMD report are available by the following links.

10.12.2021

We are pleased to invite you in our stand 3E57, hall 3 to explore innovations of PCR technology. Reserve a time slot sending request to info@dna-technology.com
We are looking forward to meeting you!

11.11.2021

We are pleased to announce the publication of the ORIGINAL RESEARCH in BIOMEDICAL JOURNAL OF PIROGOV UNIVERSITY (Bulletin of RSMU; Moscow, Russia) - Microbiota of semen  samples with normozoospermia: analysis of real-time PCR data; Voroshilina ES, Zornikov DL, Ivanov AV, Pochernikov DG, Panacheva EA.

READ

02.11.2021

Experts from the World Health Organization have checked the quality of PCR analysis performed by the Biomedica laboratory (the Company's partner in Georgia). Reagents kits for the detection of SARS-CoV-2 manufactured by DNA-Technology received the highest rating as the most accurate test system. The report can be found here

21.10.2021

Our company has received a confirmation of the fulfillment of applicable requirements of the European Council Directive 98/79/EC and now officially holds the right to affix CE marking on the following products:

29.07.2021

We are pleased to announce the launch of our new AVRI Panel Multiplex PCR kit.  The kit can be used in the research practice and does not depend on population and demographic aspects. More information about the kit is available on the product page

28.07.2021

Страницы